PUBLISHER: The Business Research Company | PRODUCT CODE: 1938964
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938964
Dialysis devices and equipment serve the purpose of filtering a patient's blood, eliminating waste products such as urea, creatinine, and excess water in cases where the kidneys fail, are damaged, dysfunctional, or absent.
The primary categories of dialysis devices and equipment include hemodialysis devices and peritoneal dialysis devices. Hemodialysis is a procedure in which a specialized machine, along with an artificial kidney or dialyzer, is employed to purify the blood. The applications of these devices encompass serum and blood treatment, virus purification, drug binding studies, among others. The end-users of dialysis devices and equipment span hospitals, clinics, ambulatory surgical centers, and home care settings.
Tariffs are influencing the dialysis devices and equipment market by increasing costs of imported dialysis machines, filters, membranes, tubing sets, electronic components, and medical-grade plastics used across hemodialysis and peritoneal dialysis systems. Hospitals and dialysis centers in North America and Europe are most affected due to reliance on imported consumables and equipment, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are raising treatment costs and pressuring healthcare budgets. However, they are also promoting domestic production of dialysis consumables, regional manufacturing hubs, and innovation in cost-optimized renal replacement therapies.
The dialysis devices and equipment market research report is one of a series of new reports from The Business Research Company that provides dialysis devices and equipment market statistics, including dialysis devices and equipment industry global market size, regional shares, competitors with a dialysis devices and equipment market share, detailed dialysis devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the dialysis devices and equipment industry. This dialysis devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dialysis devices and equipment market size has grown steadily in recent years. It will grow from $13.62 billion in 2025 to $14.28 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increasing incidence of chronic kidney disease, expansion of hospital dialysis infrastructure, improved availability of hemodialysis machines, rising aging population, growth of renal care clinics.
The dialysis devices and equipment market size is expected to see strong growth in the next few years. It will grow to $17.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing demand for home-based dialysis therapies, rising investments in next-generation dialysis technologies, expansion of tele-nephrology services, growing focus on cost-effective renal care, increasing adoption of wearable dialysis devices. Major trends in the forecast period include increasing adoption of home dialysis systems, rising use of automated peritoneal dialysis devices, growing integration of remote patient monitoring, expansion of portable dialysis equipment, enhanced focus on patient safety and treatment efficiency.
The increasing prevalence of hypertension is anticipated to drive the growth of the dialysis devices and equipment market in the coming years. Hypertension is a medical condition marked by persistently high pressure in the blood vessels. During hemodialysis, blood is filtered outside the body using a machine, which helps regulate blood pressure and maintain the balance of essential minerals such as potassium, sodium, and calcium in the bloodstream. Hemodialysis can substitute part of kidney function, though not entirely, helping improve energy levels and reduce fluid accumulation in the body between treatment sessions. For example, in September 2025, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations, global estimates indicated that in 2024 approximately 1.4 billion adults aged 30-79 were living with hypertension-around one-third of this population-with two-thirds residing in low- and middle-income countries, 600 million unaware of their condition, nearly 630 million receiving treatment, and only about 320 million achieving controlled blood pressure. Thus, the growing prevalence of hypertension is contributing to the expansion of the dialysis devices and equipment market.
Leading players operating in the dialysis devices and equipment market are concentrating on developing advanced solutions, such as AI-driven remote monitoring, to improve accessibility and the quality of care. AI-driven remote monitoring involves the integration of artificial intelligence and cloud-based platforms into dialysis machines to transmit real-time data to clinicians, enabling improved clinical decision-making, continuous monitoring, and early identification of complications. For instance, in February 2025, Renalyx Health Systems, an India-based provider of renal care technology, introduced the RENALYX-RxT 21, India's first fully indigenous smart hemodialysis machine equipped with real-time cloud connectivity and tele-nephrology capabilities. The system delivers critical-care-level support for patients with cardiovascular conditions or acute kidney injury and facilitates end-stage renal disease treatment, while being priced substantially lower than imported alternatives. Manufactured in India, it addresses demand gaps in semi-urban and rural areas and is supported by plans to scale production to several thousand units over the next few years.
In December 2024, Nipro Corporation, a Japan-based manufacturer of medical devices including dialysis equipment, acquired a 70% stake in Sichuan Pure Science & Technology Co., Ltd., a China-based producer of reverse-osmosis (RO) dialysis water purification systems, for an undisclosed sum. Through this acquisition, Nipro seeks to strengthen its footprint in the Chinese renal care market, expand its dialysis product portfolio, and enhance its global competitiveness in hemodialysis solutions. Sichuan Pure is a China-based company specializing in the production of RO systems that purify water for dialysis centers, supporting safe and efficient dialysis treatment.
Major companies operating in the dialysis devices and equipment market are Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., Nipro Corporation, B. Braun Medical Inc., Nikkiso Co. Ltd., Asahi Kasei Corporation, Toray Medical Co. Ltd., JMS Co. Ltd., Kawasumi Laboratories Inc., Terumo Corporation, DaVita Inc., NxStage Medical Inc., Outset Medical Inc., Renalyx Health Systems, Medikit Co. Ltd., Otsuka Medical Devices Co. Ltd., Shanwaishan Medical Group, Bain Medical Equipment Co. Ltd., Jiangsu Lengthen Life Science and Technology Co. Ltd., Shenzhen Landwind Industry Co. Ltd.
Asia-Pacific was the largest region in the global dialysis devices and equipment market in 2025. North America was the second largest market in dialysis devices and equipment market. The regions covered in the dialysis devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the dialysis devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The dialysis devices and equipment market consist of sales of instruments such as dialyzers, dialysis pumping machines, blood pumps, catheters, and tubing kits that are used for dialysis. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dialysis Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses dialysis devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for dialysis devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dialysis devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.